Fate Therapeutics Inc (FATE)
4.545
-0.24
(-5.10%)
USD |
NASDAQ |
Apr 23, 16:00
4.535
-0.01
(-0.22%)
After-Hours: 18:00
Fate Therapeutics Profit Margin (Quarterly): -2.63K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.63K% |
| September 30, 2023 | -2.32K% |
| June 30, 2023 | -5.65K% |
| March 31, 2023 | -32.01% |
| December 31, 2022 | -127.1% |
| September 30, 2022 | -557.8% |
| June 30, 2022 | -410.3% |
| March 31, 2022 | -356.7% |
| December 31, 2021 | -402.0% |
| September 30, 2021 | -304.4% |
| June 30, 2021 | -411.1% |
| March 31, 2021 | -404.7% |
| December 31, 2020 | -334.1% |
| September 30, 2020 | -776.4% |
| June 30, 2020 | -513.7% |
| March 31, 2020 | -1.33K% |
| December 31, 2019 | -1.01K% |
| September 30, 2019 | -1.10K% |
| June 30, 2019 | -833.4% |
| March 31, 2019 | -750.8% |
| December 31, 2018 | -964.9% |
| September 30, 2018 | -1.64K% |
| June 30, 2018 | -1.91K% |
| Date | Value |
|---|---|
| March 31, 2018 | -1.38K% |
| December 31, 2017 | -1.22K% |
| September 30, 2017 | -1.04K% |
| June 30, 2017 | -940.1% |
| March 31, 2017 | -986.0% |
| December 31, 2016 | -773.1% |
| September 30, 2016 | -851.6% |
| June 30, 2016 | -818.7% |
| March 31, 2016 | -633.7% |
| December 31, 2015 | -692.0% |
| September 30, 2015 | -671.2% |
| June 30, 2015 | -2.36K% |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | -2.91K% |
| June 30, 2013 | -1.91K% |
| March 31, 2013 | -751.7% |
| December 31, 2012 | -646.2% |
| September 30, 2012 | -779.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-5.65K%
Minimum
Jun 2023
-32.01%
Maximum
Mar 2023
-1.03K%
Average
-513.7%
Median
Jun 2020
Profit Margin (Quarterly) Benchmarks
| Amicus Therapeutics Inc | -29.41% |
| Regeneron Pharmaceuticals Inc | 33.77% |
| Sarepta Therapeutics Inc | 11.51% |
| ADMA Biologics Inc | -23.88% |
| Ocular Therapeutix Inc | -197.4% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -37.07% |
| Return on Assets | -27.09% |
| Return on Invested Capital | -37.07% |
| Operating Margin (Quarterly) | -2.87K% |
| Return on Net Operating Assets | -89.35% |